R&D News | pharmaphorum

News

Imec will demonstrate an ingestible sensor device today that can monitor gut health and could be a valuable tool for research and clinical trials.

News

The decision by the UK to set new 10-year budgets for public R&D funding has received a positive response from academia and the pharma industry.

News

Pfizer has joined the ranks of those developing cancer drugs that target PD-1 and VEGF, penning a $6bn licensing deal with China's 3SBio.

News

The partner of disgraced ex-Theranos CEO Elizabeth Holmes, Billy Evans, has reportedly raised millions of dollars for another blood testing startup.

News

BioMarin has made its first M&A play under James Sabry, buying Inozyme to flesh out its enzyme replacement therapies (ERTs) for rare diseases.

News

Novo Nordisk's chief executive Lars Fruergaard Jørgensen is stepping down by "mutual agreement" with the company's board.